Complementary methods provide evidence for the expression of CXCR7 on human B cells

Proteomics

Volumn 12, Issue 12, 2012, Pages 1938-1948

  Humpert, Marie Luise ^a   Tzouros, Manuel ^b   Thelen, Sylvia ^a   Bignon, Alexandre ^c,d   Levoye, Angélique ^e   Arenzana Seisdedos, Fernando ^e   Balabanian, Karl ^c,d   Bachelerie, Françoise ^e,f   Langen, Hanno ^b   Thelen, Marcus ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

^e INSTITUT PASTEUR   (France)

^f Universite Paris Sud   (France)

Author keywords

B cells; Cell biology; CXCL12; CXCR4; CXCR7; Leukocytes

Indexed keywords

ANTIBODY; CHEMOKINE RECEPTOR CXCR7; MESSENGER RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; COMPLEMENTARY METHOD; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; DOGS; FLUORESCENT DYES; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PALATINE TONSIL; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR; RNA, MESSENGER; TRANSFECTION;

EID: 84862976267     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100581     Document Type: Article

References (68)

1. Schwartz, T. W., Frimurer, T. M., Holst, B., Rosenkilde, M. M. et al., Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 2006, 46, 481-519.
2. Pierce, K. L., Premont, R. T., Lefkowitz, R. J., Signalling: seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002, 3, 639-650.
3. Thelen, M., Dancing to the tune of chemokines. Nat. Immunol. 2001, 2, 129-134.
4. Walsh, G., Jefferis, R., Posttranslational modifications in the context of therapeutic proteins. Nat. Biotechnol. 2006, 24, 1241-1252.
5. Costagliola, S., Panneels, V., Bonomi, M., Koch, J. et al., Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J. 2002, 21, 504-513.
6. Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R. et al., Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999, 96, 667-676.
7. Baribaud, F., Edwards, T. G., Sharron, M., Brelot, A. et al., Antigenically distinct conformations of CXCR4. J. Virol. 2001, 75, 8957-8967.
8. Bennett, L. D., Fox, J. M., Signoret, N., Mechanisms regulating chemokine receptor activity. Immunology 2011, 134, 246-256.
9. Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F. et al., CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signalling. Blood 2009, 113, 6085-6093.
10. Mantovani, A., Bonecchi, R., Locati, M., Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 2006, 6, 907-918.
11. Ulvmar, M. H., Hub, E., Rot, A., Atypical chemokine receptors. Exp. Cell Res. 2011, 317, 556-568.
12. Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M. et al., Control of chemokine-guided cell migration by ligand sequestration. Cell 2008, 132, 463-473.
13. Luker, K. E., Steele, J. M., Mihalko, L. A., Ray, P. et al., Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010, 29, 4599-4610.
14. Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H. et al., CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS. ONE. 2010, 5, e9175.
15. Jamieson, T., Cook, D. N., Nibbs, R. J., Rot, A. et al., The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 2005, 6, 403-411.
16. Comerford, I., Milasta, S., Morrow, V., Milligan, G. et al., The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. Eur. J. Immunol. 2006, 36, 1904-1916.
17. Colditz, I. G., Schneider, M. A., Pruenster, M., Rot, A., Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb. Haemost. 2007, 97, 688-693.
18. Burns, J. M., Summers, B. C., Wang, Y., Melikian, A. et al., A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 2006, 203, 2201-2213.
19. Zabel, B. A., Wang, Y., Lewen, S., Berahovich, R. D. et al., Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J. Immunol. 2009, 183, 3204-3211.
20. Cruz-Orengo, L., Holman, D. W., Dorsey, D., Zhou, L. et al., CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 2011, 208, 327-339.
21. Rajagopal, S., Kim, J., Ahn, S., Craig, S. et al., {beta}-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc. Natl. Acad. Sci. USA 2010, 107, 628-632.
22. Odemis, V., Boosmann, K., Heinen, A., Kury, P. et al., CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J. Cell Sci. 2010, 123, 1081-1088.
23. Luker, K. E., Gupta, M., Steele, J. M., Foerster, B. R. et al., Imaging ligand-dependent activation of CXCR7. Neoplasia. 2009, 11, 1022-1035.
24. Kalatskaya, I., Berchiche, Y. A., Gravel, S., Limberg, B. J. et al., AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol. Pharmacol. 2009, 75, 1240-1247.
25. Decaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S. et al., CXCR7/CXCR4 heterodimer constitutively recruits {beta}-arrestin to enhance cell migration. J. Biol. Chem. 2011, 286, 32188-32197.
26. Sierro, F., Biben, C., Martinez-Munoz, L., Mellado, M. et al., Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 2007, 104, 14759-14764.
27. Luker, K. E., Gupta, M., Luker, G. D., Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J. 2008, 23, 823-834.
28. Miller, R. J., The magnificent seventh. Neuron 2011, 69, 1-3.
29. Sanchez-Alcaniz, J. A., Haege, S., Mueller, W., Pla, R. et al., Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 2011, 69, 77-90.
30. Wang, Y., Li, G., Stanco, A., Long, J. E. et al., CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 2011, 69, 61-76.
31. Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y. et al., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 2005, 280, 35760-35766.
32. Zabel, B. A., Lewen, S., Berahovich, R. D., Jaen, J. C. et al., The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol. Cancer 2011, 10, 73.
33. Sun, X., Cheng, G., Hao, M., Zheng, J. et al., CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 2010, 29, 709-722.
34. Berahovich, R. D., Zabel, B. A., Penfold, M. E., Lewen, S. et al., CXCR7 protein is not expressed on human or mouse leukocytes. J. Immunol. 2010, 185, 5130-5139.
35. Infantino, S., Moepps, B., Thelen, M., Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J. Immunol. 2006, 176, 2197-2207.
36. Jin, Z., Nagakubo, D., Shirakawa, A. K., Nakayama, T. et al., CXCR7 is inducible by HTLV-1 tax and promotes growth and survival of HTLV-1-infected T cells. Int. J. Cancer 2009, 125, 2229-2235.
37. Sebzda, E., Zou, Z., Lee, J. S., Wang, T. et al., Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat. Immunol. 2008, 9, 292-300.
38. Winkelmann, R., Sandrock, L., Porstner, M., Roth, E. et al., B cell homeostasis and plasma cell homing controlled by Kruppel-like factor 2. Proc. Natl. Acad. Sci. USA 2010.
39. Hartmann, T. N., Grabovsky, V., Pasvolsky, R., Shulman, Z. et al., A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 2008, 84, 1130-1140.
40. Shimizu, N., Soda, Y., Kanbe, K., Liu, H. Y. et al., A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. J. Virol. 2000, 74, 619-626.
41. Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L. et al., Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J. Immunol. 2006, 177, 1941-1955.
42. Sanchez-Martin, L., Estecha, A., Samaniego, R., Sanchez-Ramon, S. et al., The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 2010, 117, 88-97.
43. Werner, L., Elad, H., Brazowski, E., Tulchinsky, H. et al., Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease. J. Leukoc. Biol. 2011, 90, 583-590.
44. Wang, H., Beaty, N., Chen, S., Qi, C. F. et al., The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 2012, 119, 465-468.
45. Chow, K. Y., Brotin, E., Ben, K. Y., Carthagena, L. et al., A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host. Microbe 2010, 8, 523-533.
46. Welch, H. C., Condliffe, A. M., Milne, L. J., Ferguson, G. J. et al., P-rex1 regulates neutrophil function. Curr. Biol. 2005, 15, 1867-1873.
47. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. et al., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31, 3388-3393.
48. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B. et al., Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell Proteomics 2005, 4, 2010-2021.
49. Zhou, Z., Cironi, P., Lin, A. J., Xu, Y. et al., Genetically encoded short peptide tags for orthogonal protein labeling by Sfp and AcpS phosphopantetheinyl transferases. ACS Chem. Biol. 2007, 2, 337-346.
50. Copp, J. N., Neilan, B. A., The phosphopantetheinyl transferase superfamily: phylogenetic analysis and functional implications in cyanobacteria. Appl. Environ. Microbiol. 2006, 72, 2298-2305.
51. George, N., Pick, H., Vogel, H., Johnsson, N. et al., Specific labeling of cell surface proteins with chemically diverse compounds. J. Am. Chem. Soc. 2004, 126, 8896-8897.
52. Amara, A., Le Gall, S., Schwartz, O., Salamero, J. et al., HIV coreceptor downregulation as antiviral principle: SDF- 1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 1997, 186, 139-146.
53. Thoma, G., Streiff, M. B., Kovarik, J., Glickman, F. et al., Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo. J. Med. Chem. 2008, 51, 7915-7920.
54. Walther, T. C., Mann, M., Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 2010, 190, 491-500.
55. Babcock, G. J., Mirzabekov, T., Wojtowicz, W., Sodroski, J., Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J. Biol. Chem. 2001, 276, 38433-38440.
56. Lagane, B., Chow, K. Y., Balabanian, K., Levoye, A. et al., CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 2008, 112, 34-44.
57. Luker, K., Gupta, M., Luker, G., Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques 2009, 47, 625-632.
58. Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C. et al., Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J. Exp. Med. 2008, 205, 479-490.
59. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A. et al., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52, 145-176.
60. Berger, E. A., Murphy, P. M., Farber, J. M., Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17, 657-700.
61. Jujo, K., Hamada, H., Iwakura, A., Thorne, T. et al., CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl. Acad. Sci. USA 2010, 107, 11008-11013.
62. Pusic, I., DiPersio, J. F., Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr. Opin. Hematol. 2010, 17, 319-326.
63. McDermott, D. H., Lopez, J., Deng, F., Liu, Q. et al., AMD3100 is a potent antagonist at CXCR4 (R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. J. Cell Mol. Med. 2010.
64. Smith, M. C., Luker, K. E., Garbow, J. R., Prior, J. L. et al., CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004, 64, 8604-8612.
65. Miao, Z., Luker, K. E., Summers, B. C., Berahovich, R. et al., CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc. Natl. Acad. Sci. USA 2007, 104, 15735-15740.
66. Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A. et al., Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 1999, 274, 23916-23925.
67. Kuscher, K., Danelon, G., Paoletti, S., Stefano, L. et al., Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes. Eur. J. Immunol. 2009, 39, 1118-1128.
68. Liu, S. M., Xavier, R., Good, K. L., Chtanova, T. et al., Immune cell transcriptome datasets reveal novel leukocyte subset-specific genes and genes associated with allergic processes. J. Allergy Clin. Immunol. 2006, 118, 496-503.